NCT01262365 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT01261793 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE3
NCT01240694 A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus Status TERMINATED Phase PHASE3
NCT01205438 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT01196091 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT01176643 Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase NA
NCT01164917 Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus Status TERMINATED Phase PHASE1
NCT01162681 PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01135459 A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT01112215 Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations Status COMPLETED Phase PHASE4
NCT01101802 Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) Status COMPLETED Phase PHASE4
NCT01058343 Safety of IFNa Kinoid in Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1/PHASE2
NCT01031836 A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. Status COMPLETED Phase PHASE2
NCT01018238 An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) Status WITHDRAWN Phase PHASE1
NCT00997100 Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2